Bibliografia. Agència de Salut Pública de Catalunya (ASPCAT)

Is methadone too dangerous for opiate addiction? The case for using a safer alternative, buprenorphine, is strong. BMJ. 2009; 331 (editorials): 1352-3.
Anoro M, Llundain E, Rodríguez R, Rosell E, Iglesias B. Risk factors associated to severe opiate overdose in an open-air drug scene. ABD Associació Benestar i Desenvolupament. 2009. Ashton H, Hassan Z. Intranasal naloxone in suspected opioid overdose. Emerg. Med Journal. 2009; 23: 221-223. Australian National Council on Drugs. High risk groups and behaviours. A secondary position paper on heroin related overdoses. 2000.
Australian National Council on Drugs. Naloxone availability. A secondary position paper on heroin related overdoses. 2009. Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction. 2005; 1823-1831. Baca CT, Grant KJ. What heroin users tell us about overdose. Journal of Addictive Diseases. 2007; 26 (4): 63-8.
Bammer G, Sengoz A. The Canberra Christmas overdoses mystery. Drug and Alcohol Review. 1995; 14: 235-7.
Bernstein KT, Bucciarelli A, Markham PT, Gross C, Tardiff K, Galea S. Cocaine- and opiate-related fatal overdose in New York City, 1990-2000. BMC Public Health. 2007 Mar 9; 7 (31): 1.
Bigg D. Data on take home naloxone are unclear but not condemnatory. BMJ. 2002; 324: 678. Brugal MT, Barrio G, De la Fuente L, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction. 2002; 97 (3): 319-27.
Brugal MT. Morbi-mortalidad asociada al consumo de heroína. 2005.
Conway AC. Maine Center for Public Health, Maine Public Health Association. A report from MCPH/MPHA/OSA opiate abuse and overdose project. 2002 Dec 31.
Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction. 1996; 91 (3): 413-417.
Darke S, Zador D. Fatal heroin overdose: A review. Addiction. 1996; 91 (12): 1765-72.
Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug and Alcohol Dependence. 1996; 43 (3): 191-8.
Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003; 98 (8):1169-71.
Darke S, Williamson A, Ross J, Teesson M. Non-fatal heroin overdose, treatment exposure and client characteristics: Findings from Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review. 2005 Sep; 24: 425-32. Davoli M, Perucci CA, Forastieri F, Doyle P, Rapiti E, Zaccarelli M, et al. Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. International Journal of Epidemiology. 1992 Sep 1; 22: 273-7.
Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011; Jan 106 (1): 32-51.
Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001 Apr; 322: 895-6.
Dietze P, Jolley D, Fry C, Bammer G. Transient changes in behaviour lead to heroin overdose: results from case-crossover study of non-fatal overdose. Addiction. 2004 Dec 16; 100: 636-42.
EMCDDA, Preventing overdose deaths in Europe (Perspectives on drugs). Lisbon, October 2018
European Commission. Strategic Choices for reducing Overdose Deaths in four European Cities. A join Project of the cities of Oslo, Amsterdam, Copenhagen and Frankfurt am Main. 2002.
European Monitoring Centre for Drugs and Drug Addiction. Overdose—a major cause of avoidable death among young people. Drugs in focus. 2009.
Espelt A, Major X, Parés-Badell O, Carvajal S, Gasulla L, Bosque-Prous M, Brugal M. Implementation of Systematic Programs of Overdose Training at Drug Treatment and Prevention Centres in Catalonia, 2008-2013. A: Dichtl A, Stöver H, editors. Naloxon - Überlebenshilfe im Drogennotfall. Frankfurt: Fachhochschulverlag; 2015. p. 83-95.
Fischer B, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noël L, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association or its licensors. 2004 Aug 3; 171 (3): 235-9.
Fixpunkt e.V. BG. Naloxone distribution and the prevention of opiate overdose deaths. 2002.
Galea S, Worthington N, Markham PT, Nandi V, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as overdose prevention strategy: Early evidence from a pilot study in New York City. Addictive Behaviors. 2005; 31: 907-912.
Generalitat de Catalunya, Departament de Salut. Informe anual 2007. Sistema d’informació sobre drogodependències a Catalunya. 1-9-2007.
Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996; 313 (7054): 402.
Green TC, Heimer R, Grau LE. Distinguishing signs of opioid and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008.
Gutiérrez-Cebollada J, De la Torre R, Ortuño J, Garcés JM, Camí J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug and Alcohol Dependence. 1994; 35: 169-174. Hickman M, Carrivick S, Cusick L, Zador D, Paterson S, Hunt N. A taxonomy of preventability of overdose death: A multi-method study. NHS National Treatment Agency for Substance Misuse London. 2007 Apr; Research briefing: 23.
Kaye S, Darke S. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug Alcohol Rev. 2004; 23 (4): 391-8.
Lagu T, Anderson BJ, Stein M. Overdoses among friends: Drug users are willing to administer naloxone to others. Journal of Substance Abuse Treatment. 2006 May 3; 30: 129-33. Lenton SR, Hargreaves KM. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? MJA. 2000; 173: 260-263.
Leri F, Bruneau J, Stewart J. Understanding polydrug use: Review of heroin and cocaine co-use. Addiction. 2002 Dec 19; 98 (1): 7-22.
Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bulletin of the World Health Organization. 2013; 91. p. 102-123.
Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. Journal of Addictive Diseases. 2006; 25 (3): 89-96.
Mc Gregor C, Hall K, Ali R, Christie P, Braithwaite R, Darke S. It’s rarely just the “h”: addressing overdose among South Australian heroin users through a process of intersectoral collaboration. Drug and Alcohol Services Council South Australia. 1999; 1-27.
Ministerial Council on Drug Strategy. National Heroin Overdose Strategy. 2001.
MMWR. Unintentional opiate overdose deaths - King Country, Washington, 1990-1999. 2009.
National Treatment Agency for Substance Misuse United Kingdom (NHS). Reducing drug-related deaths. 2004.
Neale J, Robertson M. Recent life problems and non-fatal overdose among heroin users entering treatment. Addiction. 2005; 100: 168-175.
Neira-León M, Barrio G, Brugal MT, De la Fuente L, Ballesta R, Bravo MJ, et al. Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose? Journal of Urban Health 6 A.D. Jan; 83 (3): 477-96.
New York Department of Health. Opioid Overdose Prevention. Guidelines for Polices and Procedures. 2006.
NSW Health Department. NSW heroin overdose prevention and management strategy. 2007. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addictive Behaviors. 2001 May 2; 26 (3): 453-60.
Observatorio Europeo de las Drogas y las Toxicomanías (2019), Informe Europeo sobre Drogas 2019: Tendencias y novedades, Oficina de Publicaciones de la Unión Europea, Luxemburgo.
OEDT, 2011, 2013A. European Monitoring Centre for Drugs and Drug Addiction. Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone. EMCDDA Papers, Publications Office of the European Union, Luxembourg. 2015.
Oliver P, Keen J. Concomitant drugs of misuse and drug using behaviours associated whit fatal opiate-related poisonings in Sheffield, UK, 1997-2000. Addiction. 2003 Jan 15; 98 (2): 191-7. Oliver P, Forrest R, Keen J. Does the combined use of heroin or methadone and other substances increase the risk of overdose? NHS National Treatment Agency for Substance Misuse, London. 2007 Feb; Research briefing: 27.
Oliver P, Forrest R, Keen J. Benzodiazepines and cocaine as risk factors in fatal opioid overdoses. NHS National Treatment Agency for Substance Misuse, London. 2007 Mar; Research briefing: 31. Oliver P, Forrest R, Keen J. Study to determine the relationship between blood-heroin/methadone and concomitant drug levels in fatal opioid poisonings. NHS National Treatment Agency for Substance Misuse, London. 2007 Mar.
Perucci CA, Davoli M, Rapiti E, Abeni DD, Forastieri F. Mortality of intravenous drug users in Rome: a cohort study. American Journal of Public Health. 1992; 81 (10): 1307-1310.
Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, et al. Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution program in New York City. Harm Reduction Journal. 4 (3): 1-8. 1-1-2007.
Polettini A, Poloni V, Groppi A, Stramesi C, Vignali C, Politi L, et al. The role of cocaine in heroin-related deaths. Hypothesis on the interaction between heroin and cocaine. Forensic Science Int. 153 (1): 23-28. 4-10-2005.
Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee S. Response to overdose among injection drug users. American Journal of Preventive Medicine. 2006 Sep 1; 31 (3): 261-4.
Scott G, Thomas SD, Pollack HA, Ray B. Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. Journal of Urban Health. 2007; 84 (2): 292-306.
Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RN, Lorvick J, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. American Journal of Public Health. 2001 Nov; 91 (11): 1842-6.
Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone Distribution and Cardiopulmonary Resuscitation Training for Injection Drug Users to Prevent Heroin Overdose Death: A Pilot Intervention Study. Journal of Urban Health. 2005 May; 82 (2): 303-11.
Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998; 316: 426-428.
Sherman S, Gann DS, Scott G, Carlberg-Racich S, Bigg D, Heimer R. A qualitative study of overdose responses among Chicago IDUs. 2009.
Sporer KA. Strategies for preventing heroin overdose. BMJ 3 A.D. Feb 22; 326: 442-4.
Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Annals of Emergency Medicine. 2007 Feb; 49 (2): 172-7.
Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-lunch study of possible impact and acceptability. Addiction. 1999; 94 (2): 199-204.
Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003 May 3; 326:959-60.
Strang J, Kelleher M, Best D, Mayet S, Manning V. Emergency naloxone for heroin overdose. BMJ. 2006; 333: 614-615.
Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008 Jun 2; 103: 1648-57.
Strang J, Manning V, Mayet S, Titherington E, Offor E, Semmler C, et al. Family carers and prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone. Drugs: education, prevention and policy. 2008 Apr; 15 (2): 211-8.
Tobin KE, Gaasch WR, Clarke C, McKenzie E, Latkin CA. Attitudes of emergency medical service providers toward naloxone distribution programs. Journal of Urban Health. 2005 May 25; 82 (2): 296-302.
Vancouver Police Department. Guidelines for police attending illicit drug overdoses. 2006. Ref Type: Online Source.
Wanger K, Brough L, Macmillan I, Goulding J, Macmillan I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Energ Med. 1998; 5: 293-9.
Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, et al. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. International Journal of Drug Policy. 2008; 19: 332-8.
White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 2002 May 3; 94 (7): 961-72.
Williams P, Urbas G. Heroin overdoses and duty of care. Australian Institute of Criminology. Trends and Issues. 2001.
Woodruff J. Learning to breathe: users training users in overdose resuscitation. 2000.
World Health Organization. Social Change and Mental Health. Opioid Overdose: Trends, risk factors, interventions and priorities for action. 1998; 1-33.
Worthington N, Piper TM, Galea S, Rosenthal DM. Opiate users’ knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduction Journal. 2006 Jun 5; 3: 19.

Data d'actualització: 26.08.2019